Preparation method of divalent inactivated vaccines for duck virus hepatitis

A technology for duck viral hepatitis and bivalent inactivated vaccine, which can be used in antiviral agents, medical preparations containing active ingredients, pharmaceutical formulas, etc., and can solve problems such as lack of cross-protection effect

Active Publication Date: 2013-02-06
YEBIO BIOENG OF QINGDAO
View PDF1 Cites 5 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Serum neutralization assay shows lack of

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Preparation method of divalent inactivated vaccines for duck virus hepatitis
  • Preparation method of divalent inactivated vaccines for duck virus hepatitis
  • Preparation method of divalent inactivated vaccines for duck virus hepatitis

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0047] (1) Vaccine (immunogen) preparation:

[0048] 1 Preparation of virus solution for seedling production

[0049] Preparation of YBH1 strain virus liquid: Dilute the virus strain YBH1 used for production to 100 times, inoculate 100 10-day-old SPF chicken embryos into the allantoic cavity, 0.2ml per embryo, incubate at 36-37°C, and inspect the embryos twice a day. Chicken embryos that died within 48 to 120 hours after inoculation were placed at 2 to 8°C for 4 to 12 hours, and allantoic fluid, amniotic fluid and embryo bodies were collected, and the heads and limbs were removed from the embryo bodies. Homogenize with embryo fluid, freeze and thaw three times, centrifuge at 4000r / min for 30min, take the supernatant and mix it in a sterile container, store at 2-8°C. (See Table 1).

[0050] Preparation of YBHX strain virus liquid Dilute the virus species YBHX strain used for production by 100 times, inoculate 100 susceptible duck embryos of 12-13 days old in the allantoic cav...

Embodiment 2

[0071] ——Inspection of finished vaccines

[0072] 1 character

[0073] (1) Appearance Milky white emulsion.

[0074] (2) Dosage form Water-in-oil type, take a clean straw, absorb a small amount of vaccine and drop it in cold water, and it will not spread in the form of oil droplets.

[0075] (3) Stability Take 10ml of the vaccine and put it into a centrifuge tube, centrifuge at 3000r / min for 15 minutes, no water phase will precipitate out at the bottom of the tube.

[0076] (4) Viscosity is 61.6 cp according to the appendix of the current version of "Chinese Veterinary Pharmacopoeia".

[0077] 2 Inspection of the filling volume is carried out according to the appendix of the current version of "Chinese Veterinary Pharmacopoeia", and it meets the standard.

[0078] 3 Sterility test According to the appendix of the current version of "Chinese Veterinary Pharmacopoeia", the sterile growth is carried out.

[0079] 4 For safety inspection, 10 SPF chickens aged 21 to 35 days wer...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
Viscosityaaaaaaaaaa
Login to view more

Abstract

The invention relates to a preparation method of divalent inactivated vaccines for duck virus hepatitis. According to the invention, the preparation method comprises the following steps of: screening duck virus hepatitis type I YBH1 strains and novel YBHX strain vaccines with good immunogenicity from preponderant popular strains so as to prepare strains, respectively inoculating the vaccines on a chicken embryo and a duck embryo, respectively harvesting embryoid bodies and embryoid fluid of dead embryos, collecting a viral solution after the embryoid bodies and the embryoid fluid are ground and frozen-thawed, and adding an oil adjuvant for mixing and emulsifying to obtain the vaccines after the viral solution is carried out ultrafiltration and concentration and is inactivated through a formaldehyde solution. The vaccines can carry out immunization for animals and can simultaneously prevent the duck virus hepatitis caused by type I duck virus hepatitis and novel duck virus hepatitis, and the divalent inactivated vaccines for the duck virus hepatitis have the advantages of high efficiency, good safety and high protective ratio and the like.

Description

technical field [0001] The invention relates to a preparation method of a duck viral hepatitis bivalent inactivated vaccine, belonging to the field of veterinary biological products. Background technique [0002] Duck viral hepatitis (DVH) is an acute, highly fatal, contagious disease of ducklings caused by duck hepatitis virus (DHV) with liver as the main pathological change. Clinical manifestations include neurological symptoms such as spasms, convulsions, and opisthotonus, and liver swelling and hemorrhage are characteristic lesions. Ducklings aged 1 to 3 weeks are susceptible to severe disease and spread rapidly. Ducklings usually die within 1 hour after symptoms appear, and the mortality rate of 10-day-old ducklings after infection is 90% to 95%. It has become a serious hazard to duck breeding. one of the major diseases of the industry. [0003] Duck hepatitis virus (DHV) serotype DHV has 4 independent serotypes, type 1, type 2, type 3 and new type. Fan Shucai et al....

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K39/295A61K39/29A61P31/14
Inventor 徐保娟宫晓郭伟伟王龙孙健胡潇
Owner YEBIO BIOENG OF QINGDAO
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap